Literature DB >> 10738861

Differential sustained attention/vigilance changes over time in schizophrenics and controls during a degraded stimulus Continuous Performance Test.

R Mass1, K Wolf, M Wagner, C Haasen.   

Abstract

The Continuous Performance Test (CPT) is a widely used procedure for sustained attention/vigilance measurement. However, though the key index of vigilance impairment is the decrement of sensitivity over time during the test period, only few studies have examined whether schizophrenics show a larger drop in CPT performance than do healthy controls. 48 schizophrenic inpatients and 48 controls were investigated with the Munich CPT (480 visual stimuli, 25% target stimuli, one stimulus per second). Stimuli were degraded by randomly inverting 40%, 41%, 42%, or 43% of the pixels. Results were calculated separately for three consecutive trial sections. Additionally, PANSS ratings, medication, and other clinical data were documented. Schizophrenics show a vigilance decrement over time, controls show a vigilance increase. Differential vigilance changes were not related to the level of stimulus degradation. Schizophrenics performed worse than controls only at the lowest degradation level. While overall sensitivity correlated negatively with the dose of atypical neuroleptics and benzodiazepines, vigilance shifts over time correlated negatively with the dose of typical neuroleptics. Furthermore, sensitivity was related to the cognitive PANSS syndrome, number of admissions/duration of illness. Differential sensitivity decrements of schizophrenics and controls can be shown if suited CPT procedures are used. The need for basic research on experimental conditions of the CPT as well as examination of the relationship between sustained attention/vigilance decrements and clinical features of schizophrenia is suggested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738861     DOI: 10.1007/pl00007535

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  10 in total

1.  Dissociation of acute and chronic intermittent phencyclidine-induced performance deficits in the 5-choice serial reaction time task: influence of clozapine.

Authors:  David M Thomson; Allan McVie; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2010-09-29       Impact factor: 4.530

2.  Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function.

Authors:  Garry D Honey; Edith Pomarol-Clotet; Philip R Corlett; Rebekah A E Honey; Peter J McKenna; Edward T Bullmore; Paul C Fletcher
Journal:  Brain       Date:  2005-09-23       Impact factor: 13.501

3.  Kraepelin and Bleuler had it right: people with schizophrenia have deficits sustaining attention over time.

Authors:  Britta Hahn; Benjamin M Robinson; Samuel T Kaiser; Tatyana M Matveeva; Alexander N Harvey; Steven J Luck; James M Gold
Journal:  J Abnorm Psychol       Date:  2012-06-11

4.  EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants.

Authors:  Savita G Bhakta; James F Cavanagh; Jo A Talledo; Juliana E Kotz; Lindsay Benster; Benjamin Z Roberts; John A Nungaray; Jonathan L Brigman; Gregory A Light; Neal R Swerdlow; Jared W Young
Journal:  Neuropsychopharmacology       Date:  2022-01-18       Impact factor: 8.294

5.  Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.

Authors:  Samuel A Barnes; Stephen J Sawiak; Daniele Caprioli; Bianca Jupp; Guido Buonincontri; Adam C Mar; Michael K Harte; Paul C Fletcher; Trevor W Robbins; Jo C Neill; Jeffrey W Dalley
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

6.  Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline.

Authors:  R L Openshaw; D M Thomson; J M Penninger; J A Pratt; B J Morris
Journal:  Psychopharmacology (Berl)       Date:  2016-10-24       Impact factor: 4.530

7.  Effects of anterior cingulate cortex lesions on a continuous performance task for mice.

Authors:  Adam C Mar; Timothy J Bussey; Martha Hvoslef-Eide; Simon Ro Nilsson; Jonathan M Hailwood; Trevor W Robbins; Lisa M Saksida
Journal:  Brain Neurosci Adv       Date:  2018-05-29

8.  Sustained attention in intellectually gifted children assessed using a continuous performance test.

Authors:  Jiannong Shi; Ting Tao; Wei Chen; Li Cheng; Long Wang; Xingli Zhang
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

9.  The continuous performance test (rCPT) for mice: a novel operant touchscreen test of attentional function.

Authors:  Chi Hun Kim; Martha Hvoslef-Eide; Simon R O Nilsson; Mark R Johnson; Bronwen R Herbert; Trevor W Robbins; Lisa M Saksida; Timothy J Bussey; Adam C Mar
Journal:  Psychopharmacology (Berl)       Date:  2015-09-29       Impact factor: 4.530

10.  Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction.

Authors:  David M Thomson; Emma J Mitchell; Rebecca L Openshaw; Judith A Pratt; Brian J Morris
Journal:  J Psychopharmacol       Date:  2021-07-24       Impact factor: 4.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.